Cargando…
SARS-CoV-2 and pathological matrix remodeling mediators
BACKGROUND: Recognizing only sharp elevation in a short period of time, the COVID-19 SARS-CoV-2 propagation is more and more marked in the whole world. Induced inflammation afterwards infection engenders a high infiltration of immune cells and cytokines that triggers matrix metalloproteinases (MMPs)...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294315/ https://www.ncbi.nlm.nih.gov/pubmed/34286362 http://dx.doi.org/10.1007/s00011-021-01487-6 |
_version_ | 1783725209054871552 |
---|---|
author | Guizani, Imen Fourti, Nesrine Zidi, Wiem Feki, Moncef Allal-Elasmi, Monia |
author_facet | Guizani, Imen Fourti, Nesrine Zidi, Wiem Feki, Moncef Allal-Elasmi, Monia |
author_sort | Guizani, Imen |
collection | PubMed |
description | BACKGROUND: Recognizing only sharp elevation in a short period of time, the COVID-19 SARS-CoV-2 propagation is more and more marked in the whole world. Induced inflammation afterwards infection engenders a high infiltration of immune cells and cytokines that triggers matrix metalloproteinases (MMPs) activation. These endopeptidases are mediators of the lung extracellular matrix (ECM), a basic element for alveoli structure and gas exchange. METHODS: When immune cells, MMPs, secreted cytokines and several other mediators are gathered a pathological matrix remodeling occurs. This phenomenon tends to tissue destruction in the first place and a pulmonary hypertrophy and fibrosis in the second place. FINDINGS: After pathological matrix remodeling establishment, pathological diseases take place even after infection state. Since post COVID-19 pulmonary fibrosis is an emerging complication of the disease, there is an urge to better understand and characterize the implication of ECM remodeling during SARS-CoV-2 infection. CONCLUSION: Targeting MMPs and their inhibitors could be a probable solution for occurred events since there are many cured patients that remain with severe sequels even after the end of infection. |
format | Online Article Text |
id | pubmed-8294315 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-82943152021-07-21 SARS-CoV-2 and pathological matrix remodeling mediators Guizani, Imen Fourti, Nesrine Zidi, Wiem Feki, Moncef Allal-Elasmi, Monia Inflamm Res Review BACKGROUND: Recognizing only sharp elevation in a short period of time, the COVID-19 SARS-CoV-2 propagation is more and more marked in the whole world. Induced inflammation afterwards infection engenders a high infiltration of immune cells and cytokines that triggers matrix metalloproteinases (MMPs) activation. These endopeptidases are mediators of the lung extracellular matrix (ECM), a basic element for alveoli structure and gas exchange. METHODS: When immune cells, MMPs, secreted cytokines and several other mediators are gathered a pathological matrix remodeling occurs. This phenomenon tends to tissue destruction in the first place and a pulmonary hypertrophy and fibrosis in the second place. FINDINGS: After pathological matrix remodeling establishment, pathological diseases take place even after infection state. Since post COVID-19 pulmonary fibrosis is an emerging complication of the disease, there is an urge to better understand and characterize the implication of ECM remodeling during SARS-CoV-2 infection. CONCLUSION: Targeting MMPs and their inhibitors could be a probable solution for occurred events since there are many cured patients that remain with severe sequels even after the end of infection. Springer International Publishing 2021-07-20 2021 /pmc/articles/PMC8294315/ /pubmed/34286362 http://dx.doi.org/10.1007/s00011-021-01487-6 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Guizani, Imen Fourti, Nesrine Zidi, Wiem Feki, Moncef Allal-Elasmi, Monia SARS-CoV-2 and pathological matrix remodeling mediators |
title | SARS-CoV-2 and pathological matrix remodeling mediators |
title_full | SARS-CoV-2 and pathological matrix remodeling mediators |
title_fullStr | SARS-CoV-2 and pathological matrix remodeling mediators |
title_full_unstemmed | SARS-CoV-2 and pathological matrix remodeling mediators |
title_short | SARS-CoV-2 and pathological matrix remodeling mediators |
title_sort | sars-cov-2 and pathological matrix remodeling mediators |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294315/ https://www.ncbi.nlm.nih.gov/pubmed/34286362 http://dx.doi.org/10.1007/s00011-021-01487-6 |
work_keys_str_mv | AT guizaniimen sarscov2andpathologicalmatrixremodelingmediators AT fourtinesrine sarscov2andpathologicalmatrixremodelingmediators AT zidiwiem sarscov2andpathologicalmatrixremodelingmediators AT fekimoncef sarscov2andpathologicalmatrixremodelingmediators AT allalelasmimonia sarscov2andpathologicalmatrixremodelingmediators |